The prevalence of lupus anticoagulant in normal pregnancy and in women with recurrent fetal loss - recommendations for laboratory testing for lupus anticoagulant

被引:8
作者
Al-Mishari, AAA
Gader, AGMA [1 ]
Ai-Jabbari, AW
Al-Momen, AKM
El Rab, MOG
Babay, ZH
Mahmoud, N
机构
[1] King Saud Univ, King Khalid Univ Hosp, Coll Med, Dept Physiol, Coagulat Lab, Riyadh 11461, Saudi Arabia
[2] King Saud Univ, King Khalid Univ Hosp, Coll Med, Dept Obstet & Gynecol, Riyadh 11461, Saudi Arabia
[3] King Saud Univ, King Khalid Univ Hosp, Coll Med, Div Oncol & Haematol, Riyadh 11461, Saudi Arabia
[4] King Saud Univ, King Khalid Univ Hosp, Coll Med, Div Immunol, Riyadh 11461, Saudi Arabia
关键词
antiphospholipid antibodies; lupus anticoagulant; RFL; pregnancy;
D O I
10.5144/0256-4947.2004.429
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: There is wide disagreement in the literature on the rate of detection of lupus anticoagulant (LA) in women with recurrent fetal loss (RFL). The aim of this study was to determine the prevalence of LA using four phospholipid-dependant coagulation tests in a large population of Saudi women. PATIENTS AND METHODS: We determined the prevalence of LA in women with RFL (n=925), normal pregnancy (n=663), and in healthy blood donors (n=204), at the King Khalid University Hospital, Riyadh. The following coagulation tests were employed: the activated partial thromboplastin time (APTT), platelet neutralization procedure (PNP), kaolin clotting time (KCT) and the dilute Russel's viper venom test (dRVVT). RESULTS: In RFL patients, positive APTT was 10.2%, APTT+PNP 3.6%, KCT 10.5%, and dRVVT 10.9%. In normal pregnancy, the corresponding figures were 12.8%, 3.1%, 10.8%, and 5.6%. Three positive tests occurred in 2.3% of RFL patients, including APTT+KCT 3.5%, APTT+dRVVT 3.9%, and KCT+dRVVT 4.1%. The corresponding figures for normal pregnancy were 1.6% for three positive tests, and 3.0%,1.8%, 2.4%, respectively. The dRVVT was the only test that showed a rate of positive results almost double that seen in normal pregnancy. CONCLUSIONS: If only one or even two screening tests were performed, a significant number of LA positive cases would have been missed. This could make a difference to treating physicians as to the possible etiology and management of RFL. It is therefore advisable to routinely use the three tests (APTT, KCT and dRRVT) when screening for LA.
引用
收藏
页码:429 / 433
页数:5
相关论文
共 24 条
[1]   Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin [J].
Backos, M ;
Rai, R ;
Baxter, N ;
Chilcott, IT ;
Cohen, H ;
Regan, L .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1999, 106 (02) :102-107
[2]   Antiphospholipid antibodies and reproductive outcome: the current state of affairs [J].
Branch, DW .
JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 1998, 38 (01) :75-87
[3]  
BRANDT JT, 1995, THROMB HAEMOSTASIS, V74, P1185
[4]  
Cadavid A, 1999, AM J REPROD IMMUNOL, V41, P271
[5]   ETHNIC VARIATIONS IN THE HEMOSTATIC SYSTEM - COMPARISON BETWEEN ARABS, WESTERNERS (EUROPEANS AND AMERICANS), ASIANS AND AFRICANS [J].
GADER, A ;
BAHAKIM, H ;
AWADALLA, S ;
MALAIKA, S .
BLOOD COAGULATION & FIBRINOLYSIS, 1995, 6 (06) :537-542
[6]  
*HAEM COMM SOC FRA, 1992, THROMB RES, V66, P3349
[7]  
HARRIS EN, 1983, LANCET, V2, P1211
[8]   LUPUS ANTICOAGULANTS, ANTICARDIOLIPIN ANTIBODIES, AND FETAL LOSS - A CASE CONTROL STUDY [J].
INFANTERIVARD, C ;
DAVID, M ;
GAUTHIER, R ;
RIVARD, GE .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (15) :1063-1066
[9]   Recurrent pregnancy loss: an update [J].
Kutteh, WH .
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 1999, 11 (05) :435-439
[10]  
Kutteh WH, 1999, AM J REPROD IMMUNOL, V41, P133